BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2788726)

  • 1. Screening blood test identifies subclinical beryllium disease.
    Kreiss K; Newman LS; Mroz MM; Campbell PA
    J Occup Med; 1989 Jul; 31(7):603-8. PubMed ID: 2788726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history.
    Newman LS; Kreiss K; King TE; Seay S; Campbell PA
    Am Rev Respir Dis; 1989 Jun; 139(6):1479-86. PubMed ID: 2729754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk.
    Newman LS; Mroz MM; Balkissoon R; Maier LA
    Am J Respir Crit Care Med; 2005 Jan; 171(1):54-60. PubMed ID: 15374840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations.
    Kreiss K; Wasserman S; Mroz MM; Newman LS
    J Occup Med; 1993 Mar; 35(3):267-74. PubMed ID: 8455096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease.
    Mroz MM; Kreiss K; Lezotte DC; Campbell PA; Newman LS
    J Allergy Clin Immunol; 1991 Jul; 88(1):54-60. PubMed ID: 2071785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the beryllium lymphocyte proliferation test using statistical process control.
    Cher DJ; Deubner DC; Kelsh MA; Chapman PS; Ray RM
    Inhal Toxicol; 2006 Oct; 18(11):901-10. PubMed ID: 16864408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonoccupational beryllium disease masquerading as sarcoidosis: identification by blood lymphocyte proliferative response to beryllium.
    Newman LS; Kreiss K
    Am Rev Respir Dis; 1992 May; 145(5):1212-4. PubMed ID: 1586067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible beryllium sensitization in a prospective study of beryllium workers.
    Rom WN; Lockey JE; Bang KM; Dewitt C; Johns RE
    Arch Environ Health; 1983; 38(5):302-7. PubMed ID: 6651355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis of chronic berylliosis].
    Schreiber J; Zissel G; Greinert U; Galle J; Schulz KH; Schlaak M; Müller-Quernheim J
    Pneumologie; 1999 Apr; 53(4):193-8. PubMed ID: 10409861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of beryllium lymphocyte transformation tests in chronic beryllium disease.
    Williams WR; Williams WJ
    Int Arch Allergy Appl Immunol; 1982; 67(2):175-80. PubMed ID: 7056594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells.
    Saltini C; Winestock K; Kirby M; Pinkston P; Crystal RG
    N Engl J Med; 1989 Apr; 320(17):1103-9. PubMed ID: 2469014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease.
    Fontenot AP; Canavera SJ; Gharavi L; Newman LS; Kotzin BL
    J Clin Invest; 2002 Nov; 110(10):1473-82. PubMed ID: 12438445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major histocompatibility locus genetic markers of beryllium sensitization and disease.
    Saltini C; Richeldi L; Losi M; Amicosante M; Voorter C; van den Berg-Loonen E; Dweik RA; Wiedemann HP; Deubner DC; Tinelli C
    Eur Respir J; 2001 Oct; 18(4):677-84. PubMed ID: 11716174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Cluster of Beryllium Sensitization Traced to the Presence of Beryllium in Concrete Dust.
    Frye BC; Quartucci C; Rakete S; Grubanovic A; Höhne K; Mangold F; Gieré R; Müller-Quernheim J; Zissel G
    Chest; 2021 Mar; 159(3):1084-1093. PubMed ID: 32926872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of the blood beryllium lymphocyte proliferation test.
    Newman LS
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):953-6. PubMed ID: 8933041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beryllium induces IL-2 and IFN-gamma in berylliosis.
    Tinkle SS; Kittle LA; Schumacher BA; Newman LS
    J Immunol; 1997 Jan; 158(1):518-26. PubMed ID: 8977230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A canine model of beryllium-induced granulomatous lung disease.
    Haley PJ; Finch GL; Mewhinney JA; Harmsen AG; Hahn FF; Hoover MD; Muggenburg BA; Bice DE
    Lab Invest; 1989 Aug; 61(2):219-27. PubMed ID: 2755079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood testing for chronic beryllium disease.
    Kreiss K; Newman LS; Mroz M
    J Occup Med; 1991 Nov; 33(11):1188-9. PubMed ID: 1765863
    [No Abstract]   [Full Text] [Related]  

  • 19. Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response.
    Fontenot AP; Palmer BE; Sullivan AK; Joslin FG; Wilson CC; Maier LA; Newman LS; Kotzin BL
    J Clin Invest; 2005 Oct; 115(10):2886-93. PubMed ID: 16151531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic Beryllium disease after exposure to low-beryllium-content copper].
    Hasejima N; Kobayashi H; Takezawa S; Yamato K; Kadoyama C; Kawano Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Oct; 33(10):1105-10. PubMed ID: 8544383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.